Thyroid deficiency before birth alters the adipose transcriptome to promote overgrowth of white adipose tissue and impair thermogenic capacity by Harris, Shelley E. et al.
 1 
Thyroid deficiency before birth alters the adipose transcriptome to promote overgrowth of 1 
white adipose tissue and impair thermogenic capacity 2 
 3 
Shelley E Harris1, Miles J De Blasio2, Xiaohui Zhao3, Marcella Ma4, Katie Davies2, Peter Wooding 4 
FBP2, Russell S Hamilton3, Dominique Blache4, David Meredith1, Andrew J Murray2, Abigail L 5 
Fowden2 and Alison J Forhead1,2 6 
 7 
1Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, OX3 0BP, UK; 8 
2Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, 9 
CB2 3EG, UK; 3Centre for Trophoblast Research, University of Cambridge, Cambridge, CB2 3EG, UK; 10 
4Genomics-Transcriptomics Core, Wellcome Trust-MRC Institute of Metabolic Science, University 11 
of Cambridge, Cambridge, CB2 0QQ, UK; 5School of Animal Biology, University of Western 12 
Australia, 6009 Crawley, Australia 13 
 14 
Short title:  Hypothyroidism modifies fetal adipose development 15 





Background  Development of adipose tissue before birth is essential for energy storage and 20 
thermoregulation in the neonate and for cardiometabolic health in later life.  Thyroid hormones 21 
are important regulators of growth and maturation in fetal tissues.  Offspring hypothyroid in utero 22 
are poorly adapted to regulate body temperature at birth and are at risk of becoming obese and 23 
insulin resistant in childhood.  The mechanisms by which thyroid hormones regulate the growth 24 
and development of adipose tissue in the fetus, however, are unclear.   25 
Methods  This study examined the structure, transcriptome and protein expression of perirenal 26 
adipose tissue (PAT) in a fetal sheep model of thyroid hormone deficiency during late gestation.  27 
Proportions of unilocular (white) and multilocular (brown) adipocytes, and unilocular adipocyte 28 
size, were assessed by histological and stereological techniques.  Changes to the adipose 29 
transcriptome were investigated by RNA-sequencing and bioinformatic analysis, and proteins of 30 
interest were quantified by Western blotting. 31 
Results  Hypothyroidism in utero resulted in elevated plasma insulin and leptin concentrations and 32 
overgrowth of PAT in the fetus, specifically due to hyperplasia and hypertrophy of unilocular 33 
adipocytes with no change in multilocular adipocyte mass.  RNA-sequencing and genomic analyses 34 
showed that thyroid deficiency affected 34% of the genes identified in fetal adipose tissue.  35 
Enriched KEGG and gene ontology pathways were associated with adipogenic, metabolic and 36 
thermoregulatory processes, insulin resistance, and a range of endocrine and adipocytokine 37 
signalling pathways.  Adipose protein levels of signalling molecules, including phosphorylated S6-38 
kinase (pS6K), glucose transporter isoform 4 (GLUT4) and peroxisome proliferator-activated 39 
receptor γ (PPARγ), were increased by fetal hypothyroidism.  Fetal thyroid deficiency decreased 40 
uncoupling protein 1 (UCP1) protein and mRNA content, and UCP1 thermogenic capacity without 41 
any change in multilocular adipocyte mass.   42 
 3 
Conclusions  Growth and development of adipose tissue before birth is sensitive to thyroid 43 
hormone status in utero.  Changes to the adipose transcriptome and phenotype observed in the 44 
hypothyroid fetus may have consequences for neonatal survival and the risk of obesity and 45 





Congenital hypothyroidism (CH) affects approximately 1 in 2000 neonates worldwide (1).  50 
At birth, affected infants are more likely to become hypothermic (1) and a small number of studies 51 
have reported that they are at greater risk of obesity, insulin resistance and non-alcoholic fatty 52 
liver (NAFL) in childhood and young adult life, even when treated soon after diagnosis (2-6).  Low 53 
thyroid hormone status in the newborn is also commonly associated with prematurity and 54 
intrauterine growth restriction, conditions that have similar consequences for temperature control 55 
at birth and long-term metabolic health (7, 8). 56 
 Development of adipose tissue before birth is crucial for energy storage, insulation and 57 
thermogenesis in the neonatal period and for metabolic health in later life.  In the fetus, adipose 58 
tissue comprises a mixture of both white and brown adipocyte types (9).  White adipocytes, 59 
termed unilocular (UL), contain a large single lipid droplet and secrete a variety of adipokines, such 60 
as leptin, while brown adipocytes, termed multilocular (ML), are characterised by the presence of 61 
several smaller lipid droplets and an abundance of mitochondria with the capacity for non-62 
shivering thermogenesis.  Thermogenesis in ML adipocytes is enabled by the unique expression of 63 
uncoupling protein 1 (UCP1) on the inner mitochondrial membrane which uncouples the electron 64 
transport chain to generate heat.   65 
The sheep fetus is commonly used to study adipose tissue development and thyroid 66 
hormone biology before birth.  In human and ovine fetuses, adipose tissue first appears around 67 
mid-gestation with similar anatomical locations in these and other large mammalian species (10).  68 
One of the largest  adipose depots is located around the kidneys (perirenal adipose tissue, PAT) 69 
which is composed of a mixture of UL and ML adipocytes (10).  Towards term, changes in the 70 
structure and function of fetal adipose tissue are observed in preparation for the nutritional and 71 
thermoregulatory challenges at birth (9).  Differential gene expression profiles have been reported 72 
in ovine PAT perinatally as the structure of adipose tissue undergoes the transition from 73 
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predominantly ML adipocytes at birth to UL adipocyte types at two weeks of postnatal life (9, 11).  74 
In fetal sheep, leptin and UCP1 mRNA abundances in PAT increase near term, in association with 75 
rising concentrations of cortisol and triiodothyronine (T3) in the circulation (12, 13). 76 
Thyroid hormones, thyroxine (T4) and T3, have important roles in the control of growth, 77 
metabolism and development of the fetus (7).  In animal models, experimental hypothyroidism in 78 
utero modifies fetal growth and impairs the maturation and long-term functioning of organs such 79 
as the heart, brain and adipose tissue (7).  Thyroid deficiency in fetal sheep impairs adipose 80 
thermogenic capacity and the ability to maintain body temperature at birth (14).  In addition, 81 
maternal hypothyroidism during pregnancy increases visceral fat mass and causes glucose 82 
intolerance in adult rat offspring (15, 16).  Intrauterine programming of adiposity by thyroid 83 
hormones has implications for adult insulin sensitivity and metabolic disease (17).  Cross-talk 84 
between adipose tissue, especially PAT (18), liver and skeletal muscle may be mediated by 85 
adipose-derived factors such as free fatty acids and adipocytokines.  In adult humans, PAT 86 
thickness has been correlated with increased risk of conditions including hypertension, fatty liver 87 
and coronary heart disease (18).  The molecular mechanisms by which thyroid hormones regulate 88 
adipogenesis and adipose function during fetal life, with implications for offspring health in the 89 
short and longer term, are, however, poorly understood. 90 
The aims of the current study were to determine the effects of hypothyroidism in utero on 91 
the growth and development of ovine adipose tissue, and to determine the molecular mechanisms 92 
responsible using transcriptome profiling.  We tested the hypothesis that thyroid hormone 93 
deficiency during late gestation would increase and decrease the amounts of UL and ML 94 
adipocytes, respectively, and impair adipose thermogenic capacity near term.   95 
Materials and Methods 96 
Animals   97 
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All surgical and experimental procedures were carried out in accordance with UK Home 98 
Office legislation and the Animals (Scientific Procedures) Act 1986, after ethical approval by the 99 
University of Cambridge Animal Welfare and Ethical Review Body at the Department of Physiology, 100 
Development and Neuroscience, University of Cambridge, UK.  Nineteen Welsh Mountain 101 
pregnant ewes of known gestational age and carrying twin fetuses (15 female and 23 male) were 102 
used in this study.  The ewes were housed in individual pens and were maintained on 200 g/day 103 
concentrates with hay and water ad libitum and access to a salt block.  Food, but not water, was 104 
withheld from the ewes for 18-24 hours before surgery.  105 
Experimental procedures   106 
At 105-110 days of gestation (dGA; term ~ 145 ± 2 days) and under halothane anaesthesia 107 
(1.5 % halothane in O2-N2O), the twin fetuses of each ewe underwent either a thyroidectomy (TX) 108 
or a sham operation in which the thyroid gland was exposed but not removed (sham), as described 109 
previously (19, 20).  At either 129 (n=18) or 143 dGA (n=20), the fetuses were delivered by 110 
Caesarean section under general anaesthesia (20 mg/kg maternal body weight sodium 111 
pentobarbitone i.v.).  Blood samples were collected by venepuncture of the umbilical artery into 112 
EDTA-containing tubes.  Each fetus was weighed and a variety of fetal organs, including the PAT, 113 
were collected after the administration of a lethal dose of barbiturate (200 mg/kg sodium 114 
pentobarbitone i.v.). 115 
Plasma hormone measurements  116 
Umbilical plasma T3 and T4 concentrations were determined by radioimmunoassay (RIA; 117 
MP Biomedicals, Loughborough, UK); the intra-assay coefficients of variation were 3% and 5%, and 118 
the minimum levels of detection were 0.14 and 7.0 ng/ml, respectively.  Plasma insulin and 119 
cortisol concentrations were determined using ELISA kits (insulin: Mercodia, Uppsala, Sweden; 120 
cortisol: IBL International, Hamburg, Germany); the intra-assay coefficients of variation were both 121 
9%, and the minimum levels of detection were 0.025 and 2.5 ng/ml, respectively.  Plasma 122 
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concentrations of leptin, IGF-I and IGF-II were determined by RIA as previously described (21, 22).  123 
The intra-assay coefficients of variation were 4-5%, and the minimum levels of detection were 124 
0.09, 0.08 and 4.0 ng/ml, respectively. 125 
Adipose tissue histology  126 
Fetal PAT was fixed in 4 % paraformaldehyde (with 0.2 % glutaraldehyde in 0.1 M 127 
phosphate buffer, pH 7.4) and embedded in paraffin wax.  Each block of PAT was cut into 7 µm 128 
sections and stained with haematoxylin and eosin.  Sections were scanned using a NanoZoomer 129 
digital slide scanner (Hamamatsu Photonics, Welwyn, UK) to create digital images for analysis.  All 130 
stereological measurements were performed and analysed blind to the treatment group.  The 131 
percentage volumes of UL and ML adipocytes were determined using NewCAST stereological 132 
software (Visiopharm, Hoersholm, Denmark).  A point-counting grid of 25 points was applied over 133 
the adipose sections and meander sampling was used to analyse the adipocyte types.  A total of 40 134 
counting frames were used per slide to provide at least 200 points per animal.  Unilocular cells 135 
were defined as an adipocyte with a diameter larger than 60 µm, after tissue shrinkage.  136 
Unilocular cell size was determined by measuring the perimeter of 60-80 of the largest UL 137 
adipocytes using the stereology software NDP.view2 (Hamamatsu Photonics).  Tissue shrinkage 138 
was estimated by measurement of the diameter of red blood cells in each section and the 139 
perimeter measurements of each fetus were adjusted by 40-50% (23).  There was no significant 140 
difference in tissue shrinkage between the samples from the TX and sham groups.  141 
RNA-sequencing and bioinformatic analysis 142 
Total RNA was extracted from fetal PAT samples using the RNeasy Lipid Tissue Mini Kit 143 
(Qiagen, Manchester, UK) and cDNA libraries were prepared in samples with RIN>6 (Agilent 144 
bioanalyser 2100 system, Agilent Technologies TDA UK Limited, Stockport, UK).  Briefly, mRNA was 145 
enriched from total RNA before reverse transcription, and adenylation and barcode ligation was 146 
performed after the synthesis of double stranded cDNA.  Ligated libraries were enriched with a 147 
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limited amplification.  Indexed libraries were normalized, pooled and sequenced on the Illumina 148 
HiSeq 4000 platform with single end reads (SE50) at the Genomics Core Facility, Cancer Research 149 
UK Cambridge Institute, Cambridge, UK. 150 
For each library, original reads files were quantified, trimmed and aligned to the Ovis aries 151 
(sheep) genome assembly Oar_v3.1 from the International Sheep Genome Consortium using 152 
ClusterFlow pipeline tool (version v0.5 dev, fastqc_star pipeline; 24), including the following 153 
software: fastqc (version 0.11.5; 25), trim_galore (version 0.4.2; 26), fastq_screen (version 0.9.3; 154 
27), MultiQC (version 0.9dev; 28) and read alignment software STAR (version 2.5.1b_modified; 155 
29).  Further details can be found in the data report (https://github.com/CTR-BFX/2019_AJF).  156 
Mapped reads were sorted and indexed with Samtools (30).  Subread software (version 1.5.0-p2; 157 
31) with the function featureCounts was applied to the indexed bam files to count the mapped 158 
reads/fragments per annotated gene from the annotation GTF file provided for the sheep genome 159 
(Oar_v3.1) release.  160 
As the nucleotide sequences for the thyroid hormone receptor (TR) isoforms, α1 and α2, 161 
were not available for sheep, highly similar porcine sequences were used to map their genomic 162 
positions in the sheep genome using BLAT (32; https://genome-euro.ucsc.edu/cgi-bin/hgBlat).  163 
From the BLAT results, a bed12 file was created to isolate the exon positions for the TRα1 and 164 
TRα2 isoforms.  Individual RNA-seq alignment files from each of the treatment groups were 165 
merged and loaded into Integrative Genomics Viewer (IGV, genome Oar_v3.1). 166 
Initial quality control included PCA and data from two fetuses were removed as outliers 167 
before further analysis.  Differentially expressed genes were identified using R (version 3.5.3) 168 
DESeq2 package (version 1.22.2; 33), using variance stabilizing transformed expression for counts.  169 
Genes with more than one read across all samples within a contrast were retained.  Additional 170 
filtering of genes with low mean read counts was automatically applied by DESeq2.  For each 171 
contrast, differentially expressed genes with Benjamini-Hochberg adjusted P-values < 0.05 were 172 
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identified.  Log2 fold change in gene expression was plotted against the mean of read counts 173 
normalized by library size for each gene in MA plots.  Significant differentially expressed genes 174 
from each comparison, within and between treatment and gestational age groups, were plotted in 175 
volcano plots and a summary of the numbers of genes in the intersections of the comparisons 176 
were plotted using UpSetR (version 1.4.0).  For heatmap analysis, gene-level transcripts expression 177 
values were derived by normalised transformed values estimated by DESeq2 for each sample.  178 
A Bayesian method (lfcshrink) implemented in DESeq2 was used to moderate the log2 fold 179 
changes obtained for genes with low or variable expression levels.  Upregulated and 180 
downregulated genes in different contrasts (BH-adjusted p < 0.01 and absolute log2 fold change > 181 
1) were analysed for gene ontology (GO) term enrichment.  Gene sets were analysed for over-182 
representation of BP (biological process) and KEGG pathway using R package clusterProfiler 183 
(version 3.10.1).  Significantly enriched terms were identified by applying the default 184 
clusterProfiler algorithm coupled with the Fisher’s exact test statistic (P ≤ 0.05, q ≤ 0.05).  Gene 185 
ontology plots were drawn using R package ggplot2 (version 3.2.1).  Normalised read counts were 186 
used in the statistical analysis of mRNA abundance of key genes.  The raw sequencing data and 187 
data reports are deposited at ArrayExpress with experimental code E-MTAB-8396.  Expression-188 
count data are available online at https://github.com/CTR-BFX/2019_AJF. 189 
Western blotting 190 
Frozen samples of fetal PAT were homogenised in cold lysis buffer (100 mg/ml; 20 mM 191 
sodium orthovanadate, 10 mM β-glycerol phosphate, 50 mM sodium fluoride and protease 192 
inhibitor cocktail (Roche, Burgess Hill, UK)) in Lysing Matrix-D tubes using a Super FastPrep 1 193 
homogeniser (MP Biomedicals, Loughborough, UK).  Samples were centrifuged at 15000g for 10 194 
minutes at 4°C.  Extracted protein concentration was measured by a bicinchoninic acid protein 195 
assay (Sigma, Poole, UK).  Prior to loading, samples were mixed with NuPage 4 x lithium dodecyl 196 
sulphate (LDS) loading buffer (2% LDS, 141 mM Tris base, 10% glycerol, 0.51 mM EDTA, 0.22 mM 197 
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Blue G, 0.175 mM Phenol Red; Life Technologies, Loughborough, UK) and 100 mM DL-198 
dithiothreitol, and heated to 70°C for 10 minutes (with the exception of those for pS6K 199 
quantification, which were heated to 99°C for 5 minutes).  Equal amounts (100 µg) of sample 200 
protein were separated using 7.5% Mini-PROTEAN pre-cast gels (Bio-Rad, Hemel Hempstead, UK) 201 
for 50 minutes at 150V and transferred for 10 minutes at 11V onto a polyvinylidene difluoride 202 
membrane (Immobilon P 0.45 µm, Millipore, Sigma) using the Pierce G2 Fast Blotter (Thermo 203 
Scientific, Loughborough, UK).  The membrane was incubated with 2.5% non-fat milk (or bovine 204 
serum albumin for phosphorylated proteins) in Tris-buffered saline with 0.1% Tween-20 for 1 hour 205 
at room temperature, followed by incubation overnight at 4°C with primary antibodies: rabbit 206 
polyclonal anti-InsRβ (10 µg/ml, Santa Cruz Biotechnologies, Heidelberg, Germany), rabbit 207 
polyclonal anti-IGF-1Rβ (10 µg/ml, Santa Cruz Biotechnologies), rabbit polyclonal anti-leptin 208 
receptor (1 µg/ml, Biorbyt, Cambridge, UK), rabbit polyclonal anti-pAkt (1:800, Ser473, Cell 209 
Signalling Technology, Hitchin, UK), mouse monoclonal anti-Akt1 (1:1000, Cell Signalling 210 
Technology), rabbit monoclonal anti-Akt2 (1:1000, Cell Signalling Technology), rabbit polyclonal 211 
anti-pmTOR (1:800, Ser 2448, Cell Signalling Technology), rabbit polyclonal anti-pS6K (1:1000, Thr 212 
389, Cell Signalling Technology), rabbit polyclonal anti-GLUT4 (2.5 µg/ml, Abcam, Cambridge, UK), 213 
mouse monoclonal anti-PCNA (2 mg/L, Dako, Cambridge UK), rabbit polyclonal anti-PPARγ (4 214 
µg/ml, Biorbyt) and rabbit polyclonal anti-UCP1 (1:500, Abcam).  Each membrane was incubated 215 
with a horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibody (GE 216 
Healthcare, Amersham, UK) for 1 hour at room temperature.  Protein expression was visualised by 217 
addition of Clarity Western ECL chemiluminescence substrate (Bio-Rad, Hemel Hempstead, UK) 218 
and quantified using Image Lab software (ChemiDoc, Bio-Rad) after normalisation to Ponceau S 219 
staining (34).  All data were normalised to a quality control sample across all gels and expressed as 220 
fold changes, relative to the sham group at 129 dGA, in arbitrary units. 221 
 222 
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Citrate synthase activity 223 
Citrate synthase (CS) activity was measured in homogenised PAT samples by a 224 
spectrophotometric enzyme assay.  The assay buffer (pH 8) contained 0.1 mM 5,5’-dithio-bis-2-225 
nitrobenzoic acid, 1 mM oxaloacetate and 0.3 mM acetyl-CoA.  Adipose CS activity was 226 
determined from the maximum rate of change of absorbance at 412 nm and 37°C (rate of 227 
thionitrobenzoic acid production) over 3-minute periods and was expressed as µmoles per minute 228 
per mg protein, measured by a bicinchoninic acid protein assay. 229 
Statistical methods   230 
Data were analysed by three-way ANOVA with treatment, gestational age and sex of the 231 
fetus as factors (SigmaStat 3.5, Systat Software, San Jose, California, USA).  The sex of the fetus 232 
had no significant effect on any of the variables measured; data from male and female fetuses 233 
were, therefore, combined and analysed by two-way ANOVA followed by the Tukey post-hoc test.  234 
Relationships between variables were assessed by Pearson’s correlation.  Significance was 235 
regarded as P˂0.05. 236 
Results 237 
Hypothyroidism in utero increases circulating insulin and leptin concentrations 238 
In TX fetuses, plasma T4 and T3 concentrations decreased to below the limits of assay 239 
detection, while plasma insulin and leptin were increased to levels above those in sham fetuses at 240 
both 129 and 143 days of gestation (dGA; P<0.05; Table 1).  The normal developmental rise in 241 
plasma cortisol concentration over this time period was observed in both groups of fetuses 242 
(P<0.05; Table 1); fetal hypothyroidism tended to suppress plasma cortisol concentration 243 
(P=0.052).  Plasma T3 increased near term in the sham fetuses (P<0.05; Table 1), while plasma 244 
concentrations of IGFI and IGFII were unaffected by TX or gestational age (Table 1). 245 
 246 
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UL-specific adipocyte growth and proliferation enlarges adipose tissue mass in hypothyroid 247 
fetuses   248 
In TX fetuses, absolute PAT weight was greater than in sham fetuses at 143 dGA (P<0.05), 249 
but not 129 dGA (Table 1); the PAT mass relative to body weight was higher in TX than sham 250 
fetuses at both ages (P<0.05, Table 1).  When expressed as a percentage of total PAT volume, 251 
sham fetuses had a greater percentage of ML relative to UL adipocyte types at 129 and 143dGA 252 
(P<0.001, Figure 1A).  In TX fetuses, there was an increase in the percentage of UL, and a decrease 253 
in ML, adipocytes compared to control values at both ages (P<0.001; Figure 1A).  When the 254 
percentage volumes of ML and UL adipocytes were expressed as absolute and relative masses, a 255 
0.95-1.30-fold increase in UL adipocyte mass was observed in the TX fetuses at both 129 and 256 
143dGA (P<0.05, Figure 1B).  The absolute and relative ML adipocyte masses, and fetal body 257 
weight, were unaffected by TX (Table 1, Figure 1B).  Positive correlations were observed between 258 
the relative UL adipocyte mass and fetal concentrations of insulin (R=0.49, N=37, P˂0.005) and 259 
leptin (R=0.68, N=38, P˂0.001).  The average perimeter of the largest UL adipocytes increased with 260 
hypothyroidism (P<0.05) and gestational age (P<0.001; Figure 1C).  These data indicate that the 261 
increase in PAT mass observed after TX was due to increased UL-specific adipocyte growth and 262 
proliferation (Figure 1D and E). 263 
Adipose transcriptome analysis reveals differential gene expression profiles in response to 264 
hypothyroidism in utero 265 
RNA-sequencing was undertaken on PAT samples from sham and TX fetuses at both 129 266 
and 143 dGA and the distribution of gene expression was assessed initially by unbiased principal 267 
component analysis (PCA).  Using the top 500 most variable genes, PCA showed distinct clustering 268 
of data based on treatment group (sham and TX) and common transcriptional profiles between 269 
gestational age within treatment groups (Supplementary Figure 1A).  Genes associated with the 270 
effect of TX, defining the principal component 1 (PC1), explained 43.5% of the variance.  These 271 
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included LPL, ELOVL6, PLIN1, FBP2 and ADIPOQ (Supplementary Figure 1B).  Genes associated with 272 
the effect of gestational age within each treatment group (principal component 2, PC2) explained 273 
14.0% of the variance and included UCP1, DIO1, FABP3 and ADRA1A (Supplementary Figure 1C).  A 274 
hierarchical clustering heatmap using 272 differentially expressed genes with an absolute log2 fold 275 
change threshold of 2 and P-adjusted < 0.05 confirmed that the transcriptome data from the sham 276 
and TX groups clustered apart (Supplementary Figure 1D). 277 
In total, 17622 genes were identified in the adipose samples from the annotated sheep 278 
genome.  Of these, 5999 genes were differentially expressed between the sham and TX groups 279 
(34.0%, P-adjusted < 0.05).  When data from all animals were considered with an absolute log2 280 
fold change ≥ 1, a total of 1472 genes were affected by hypothyroidism (768 up and 704 down-281 
regulated by TX; Supplementary Figure 2A) and 409 were affected by increasing gestational age 282 
(180 up, 229 down with increased gestational age; Supplementary Figure 2B).  When the data 283 
were analysed by age in each treatment group, the expression of 609 genes changed between 129 284 
and 143 dGA in the sham fetuses (232 up, 377 down; Supplementary Figure 2C), while this number 285 
was reduced to 174 in the TX fetuses over the same time period (86 up, 88 down; Supplementary 286 
Figure 2D).  When the data were analysed by treatment at each age, TX influenced the expression 287 
of more genes at 143 dGA (1576 total, 869 upregulated, 707 downregulated; Supplementary 288 
Figure 2F) than at 129 dGA (1090 total, 625 upregulated, 465 downregulated; Supplementary 289 
Figure 2E).  Transcriptome profiles were compared between and within treatment and gestational 290 
age groups and the results are summarised in the UpSet plot (Supplementary Figure 3A).  291 
Differentially expressed genes unique to each of the comparisons were also plotted 292 
(Supplementary Figure 3B). 293 
Gene ontology and KEGG pathway analyses identify adipogenic, metabolic, thermogenic and 294 
hormone signalling processes influenced by hypothyroidism in utero 295 
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A number of biological pathways were identified as enriched in PAT from TX fetuses.  Of 296 
particular relevance, enriched KEGG pathways were associated with regulation of lipolysis; fatty 297 
acid synthesis and metabolism; insulin resistance; AMPK, FoxO and cAMP signalling; and signalling 298 
pathways for insulin, peroxisome proliferator-activated receptor (PPAR) and adipocytokines 299 
(Figure 2A and Supplementary Figure 4).  Biological process pathways over-represented in the 300 
gene ontology analysis included fatty acid metabolism and biosynthesis, and several aspects of 301 
thermogenesis and temperature regulation (Figure 2B and Supplementary Figure 5).  When the 302 
data were assessed by treatment and age, an additional number of enriched pathways were 303 
identified in TX fetuses at 129 dGA including apelin and thyroid hormone signalling pathways 304 
(Supplementary Figure 4) and lipid metabolism (Supplementary Figure 5). 305 
Hypothyroidism in utero activates adipose PPAR and insulin-IGF signalling 306 
Key genes in some of the enriched pathways were examined in more detail and protein 307 
content was quantified by Western blotting.  Increased mRNA and protein contents of the mitotic 308 
marker, proliferating cell nuclear antigen (PCNA), and PPARγ, an important regulator of adipocyte 309 
differentiation, were observed in response to fetal hypothyroidism (P<0.005, Supplementary 310 
Figure 6A and B).  Adipose PCNA mRNA abundance decreased between 129 and 143 dGA in sham 311 
fetuses (P<0.05), and PCNA mRNA and protein contents were higher in TX compared sham fetuses 312 
at 143 dGA (P<0.05; Supplementary Figure 6A).  Compared with control values, both the mRNA 313 
and protein contents of PPARγ at 129 dGA, and mRNA abundance at 143 dGA, were greater in TX 314 
fetuses (P<0.05; Supplementary Figure 6B).  Adipose mRNA abundances of IGFI and IGFII and 315 
leptin were also increased by TX (P<0.001, Supplementary Figure 7A, B and C).  An increase in 316 
adipose IGFI mRNA was observed between 129 and 143 dGA in TX fetuses (P<0.05; Supplementary 317 
Figure 7A); over the same period, IGFII mRNA abundance decreased in both sham and TX fetuses 318 
(P<0.05; Supplementary Figure 7B). 319 
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To examine if hyperinsulinemia and increased adipose IGF mRNA abundance observed in 320 
TX fetuses were responsible, at least in part, for the greater PAT mass, the expression of insulin-321 
IGF and adipokine signalling pathways were investigated in sham and TX fetuses.  At 129 dGA, the 322 
mRNA abundance of the insulin receptor was higher, while insulin receptor β-subunit (InsRβ) 323 
protein content was lower in TX fetuses compared to sham fetuses (P<0.05, Supplementary Figure 324 
6C).  Between 129 and 143 dGA, a reduction in InsRβ protein was seen in sham, but not TX fetuses 325 
(P<0.05, Supplementary Figure 6Cii).  At 129 dGA, protein kinase β 1 (Akt1) and Akt2 mRNA, and 326 
Akt1 protein content, were greater in TX compared to sham fetuses (P<0.05, Supplementary 327 
Figure 6D-E).  In the TX fetuses, Akt2 mRNA abundance decreased between 129 and 143 dGA, and 328 
Akt2 protein content was lower at 143 dGA compared to that observed in sham fetuses (P<0.05, 329 
Supplementary Figure 6E).  The total amount of phosphorylated Akt (pAkt) protein did not change 330 
with age or fetal hypothyroidism (data not shown). 331 
A developmental rise in mRNA abundance of the mammalian target of rapamycin (mTOR) 332 
was observed in sham, but not TX fetuses (P<0.05, Supplementary Figure 6Fi); at 143 dGA only, 333 
mTOR mRNA abundance was lower in TX than sham fetuses (P<0.05, Supplementary Figure 6Fi).  334 
Fetal hypothyroidism reduced phosphorylated mTOR protein content (P<0.05), although post-hoc 335 
analysis failed to identify significant differences at either age (Supplementary Figure 6Fii).  At 129 336 
dGA, phosphorylated S6 kinase (pS6K) protein content was higher in TX than sham fetuses 337 
(P<0.05), and decreased with increasing age in TX but not sham fetuses (P<0.05, Supplementary 338 
Figure 6Gii); S6K mRNA abundance, however, was unaffected by fetal TX and age (Supplementary 339 
Figure 6Gi).  In TX fetuses, mRNA abundance of the insulin-sensitive glucose transporter, GLUT4, 340 
was greater than that observed in sham fetuses at 129 dGA and decreased towards term, unlike 341 
sham fetuses (P<0.05, Supplementary Figure 6Hi).  Adipose GLUT4 protein content was also 342 
greater in TX than sham fetuses at both ages (P<0.05, Supplementary Figure 6Hii).   343 
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Developmental increments in adipose adrenergic receptor (ADR) α1A mRNA abundance 344 
were observed between 129 and 143 dGA in both sham and TX fetuses, without any effect of TX 345 
(P<0.05, Figure 5D).  Adipose ADRβ2 mRNA abundance also increased towards term in sham but 346 
not TX fetuses; ADRβ2 mRNA abundance was lower in TX compared to sham fetuses at 143 dGA 347 
(P<0.05, Supplementary Figure 7H).  At 129 dGA, the mRNA abundance of ADRα1D was lower, 348 
while that of ADRβ1 and ADRβ3 were all higher, in TX than sham fetuses (P<0.05, Supplementary 349 
Figure 7E, G and I).  Adipose ADRα2A was increased by TX at both 129 and 143 dGA (P<0.05, 350 
Supplementary Figure 7F).  There were no effects of TX or age on the amount of the long-form 351 
leptin receptor protein, ADRα1B mRNA abundance, or the mRNA or protein abundance of the IGF 352 
type 1 receptor in PAT (data not shown).  353 
Hypothyroidism in utero impairs adipose thermogenic capacity 354 
Although the absolute and relative masses of ML adipocytes were unaffected by TX, the 355 
capacity for non-shivering thermogenesis was impaired in the PAT of TX fetuses.  Adipose citrate 356 
synthase (CS) activity, as a proxy measure of mitochondrial density, increased between 129 and 357 
143 dGA in sham but not TX fetuses (P<0.05, Table 1); CS activity in the TX fetuses was lower than 358 
control values at both ages (P<0.05, Table 1).  When observations from all fetuses were 359 
considered, regardless of gestational age or treatment group, a positive relationship was observed 360 
between adipose CS activity and the percentage volume of ML adipose tissue (R=0.53, N=37, 361 
P<0.001).  Both adipose UCP1 mRNA and protein content (both absolute values and when 362 
expressed relative to CS activity or percentage volume of ML adipose tissue) increased near term 363 
in sham fetuses, but these developmental changes were abolished by TX (Figure 3).  Absolute and 364 
relative UCP1 mRNA abundance was lower in TX compared to sham fetuses at 143 dGA (P<0.05, 365 
Figure 3A and B); relative UCP1 protein content was reduced by TX at both 129 and 143 dGA 366 
(P<0.05, Figure 3C and D) in line with previous findings at term (7). 367 
Hypothyroidism in utero alters adipose thyroid hormone metabolism and signalling 368 
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Adaptive changes in adipose mRNA abundance for the iodothyronine deiodinases (DIO) 369 
and thyroid hormone receptors (TR) were observed in response to TX.  Towards term, significant 370 
increments in the mRNA abundance of DIO1 and DIO2, which both metabolise T4 to the 371 
biologically active T3, were observed in sham but not TX fetuses (P<0.05, Figure 4A and B).  In TX 372 
fetuses, lower DIO1 mRNA level at 143 dGA, and higher DIO2 mRNA level at 129 dGA, were 373 
observed compared to the sham fetuses (P<0.05, Figure 4A and B).  Adipose mRNA levels of TRα1, 374 
TRα2 and TRβ were increased by TX at both ages (P<0.05, Figure 4C, D and E); a significant 375 
increase in adipose TRβ mRNA was observed in sham fetuses near term (P<0.05, Figure 4E).  A 376 
Sashimi plot was constructed to show the expression of the splice variants TRα1 and TRα2 377 
(Supplementary Figure 8) and adipose TRα1 and α2 mRNA levels were highly correlated when data 378 
from all animals were combined (R=0.99, N=35, P<0.0001). 379 
Discussion 380 
This study has shown for the first time that thyroid hormone deficiency modifies the 381 
transcriptome, and hence the growth and development of fetal adipose tissue, in a manner that is 382 
likely to compromise the ability of the neonate to maintain body temperature at birth and to 383 
increase its risk of metabolic dysfunction in later life.  Fetal hypothyroidism caused a shift in the 384 
relative composition of UL and ML adipocyte types towards an increase in UL adipocyte mass due 385 
to hyperplasia and hypertrophy.  Gene markers of UL adipocyte type, such as leptin, adiponectin 386 
and lipoprotein lipase, were increased in TX ovine fetuses, and adipocyte proliferation was 387 
indicated by elevated levels of the mitotic marker PCNA and enrichment of gene pathways 388 
responsible for PPARγ and insulin-IGF signalling.  The percentage of ML adipocytes in PAT was 389 
reduced by hypothyroidism in utero and, although the total amount of ML adipose tissue did not 390 
differ between sham and TX fetuses, UCP1 expression was impaired, when normalised to 391 
mitochondrial density estimated by CS activity, indicating a deficit in thermogenic capacity.  392 
Furthermore, bioinformatic analysis showed that, for a substantial number of genes, 393 
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hypothyroidism prevented the maturational changes normally seen in the transcriptome of ovine 394 
PAT near term.      395 
The effects of thyroid hormone deficiency on adipose tissue development before birth may 396 
be direct, via thyroid hormone response elements on target genes (17), and/or indirect, via 397 
changes to energy expenditure and by interactions with other nuclear receptors or changes in 398 
fetal hormone concentrations, such as insulin and the IGFs.  Basal metabolic rate is difficult to 399 
measure in utero, but previous studies have shown that thyroid hormone deficiency in the sheep 400 
fetus reduces the whole-body rate of oxygen consumption and is normalised by T4 replacement 401 
(35).  The extent to which changes in global energy expenditure induced by hypothyroidism 402 
contribute to the modifications in the growth and development of fetal PAT in the present study 403 
remain to be determined.   404 
The increased circulating concentration of insulin seen in the hypothyroid sheep fetus, 405 
secondary to pancreatic β-cell proliferation (20), is likely to be responsible, at least in part, for UL-406 
specific PAT overgrowth.  Indeed, a positive correlation was observed between fetal insulin 407 
concentration and relative UL adipocyte mass in the present study.  Before birth, insulin stimulates 408 
growth of the axial skeleton and tissues such as adipose tissue (36).  In the ovine fetus, 409 
hyperglycemia and hyperinsulinemia induced by fetal glucose infusion have also been shown to 410 
promote UL adipocyte growth with no change in ML adipocyte mass (37).  A variety of signalling 411 
pathways responsive to insulin and the IGFs, and known to be involved in the control of 412 
adipogenesis, were enriched in the adipose transcriptome by hypothyroidism in utero.  These 413 
included PPARγ, apelin and FoxO signalling.  Furthermore, measurement of selected downstream 414 
target proteins showed upregulation of pS6K, GLUT4 and PPARγ in TX fetuses.  Phosphorylation of 415 
S6K, without any change in mRNA abundance, indicated activation of the PI3-kinase pathway 416 
which is known to regulate adipogenesis via a range of transcription factors and interacting 417 
molecular pathways (38, 39).  Transgenic mice with mutation in the S6K gene are growth retarded 418 
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from embryonic life with reductions in pancreatic β-cell size and insulin content (40).  This 419 
phenotype persists to adulthood and is associated with impaired adipogenesis, increased insulin 420 
sensitivity and resistance to diet-induced obesity (41).  Increased adipose GLUT4 expression in TX 421 
sheep fetuses may also contribute to adipogenesis via enhanced glucose uptake and lipid storage 422 
and are consistent with findings in rat pups hypothyroid in fetal and neonatal life (42).   423 
 424 
While circulating IGF levels remained unchanged in TX sheep fetuses, adipose mRNA 425 
abundances for IGFI and II were elevated, indicating potential upregulation of local synthesis and 426 
paracrine actions of the IGFs.  Thyroid hormone deficiency in utero has been shown previously to 427 
modify IGF expression in liver and skeletal muscle with tissue-specific effects on growth and 428 
development in fetal sheep (43, 44).  Insulin-IGF signalling pathways can also induce the synthesis 429 
of adipokines, such as leptin, apelin and adiponectin, in part via interactions with PPARγ signalling.  430 
Previous studies have shown that hyperinsulinaemia, in the presence of euglycaemia, increases 431 
adipose leptin mRNA abundance in fetal sheep (45).  High circulating levels of thyroid-stimulating 432 
hormone associated with TX may also stimulate leptin secretion, as reported in human adipose 433 
tissue cultured in vitro (46).  The extent to which the increase in adipose adipokine expression and 434 
circulating leptin levels in the hypothyroid sheep fetus result from the greater UL adipocyte mass 435 
and/or greater capacity for adipokine synthesis and secretion in individual UL adipocytes remains 436 
to be established. 437 
Thyroid deficiency in utero reduced adipose UCP1 expression and affected several genes in 438 
the thermogenic pathway, without changing ML adipocyte mass.  Previous studies have shown 439 
that hypothyroid lambs are unable to maintain normal body temperature at delivery and their PAT 440 
contains less UCP1 and more lipid (14).  Maternal hypothyroidism in rats led to low adipose UCP1 441 
mRNA abundance in the fetuses which correlated with adipose T3 levels and was corrected by 442 
maternal thyroid hormone treatment (47).  Furthermore, in cultured brown adipocytes taken from 443 
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fetal rats, T3 causes an increase in UCP1 gene transcription, mRNA stability and mitochondrial 444 
protein content (48).  Moreover, a thyroid hormone response element (TRE) has been reported 445 
upstream of the promoter region of the UCP1 gene (49).  Suppression of adipose UCP1 levels were 446 
observed in TX sheep fetuses despite upregulation of other factors known to stimulate UCP1 447 
expression, such as ADRβ3, IGFI, leptin and PPARγ, possibly as compensatory mechanisms.  The 448 
sympathomedullary system is primarily activated at birth by delivery into a cold environment and 449 
normally interacts with thyroid hormones to promote UCP1 expression and non-shivering 450 
thermogenesis.  Although plasma catecholamine concentrations were not measured in the 451 
present study, PAT catecholamine content has been reported to be unaffected by TX in fetal sheep 452 
(50).  Previous studies have also shown that noradrenergic-induced cellular respiration in PAT is 453 
suppressed in TX sheep fetuses, compared with those infused with T3, which suggests that 454 
functional adrenergic signalling may be impaired, despite elevated PAT mRNA abundance of some 455 
ADR isoforms (51).  The effects of hypothyroidism in utero may also originate from abnormal 456 
formation of hypothalamic pathways responsible for adipose thermogenesis, especially since 457 
thyroid hormones have a key role in the development of the fetal brain (52). 458 
Maturational changes in thyroid hormone metabolism and signalling were observed in fetal 459 
adipose tissue during late gestation, which were modified by thyroid hormone deficiency.  In sham 460 
fetuses, mRNA abundances of iodothyronine deiodinases DIO1 and DIO2, and the thyroid 461 
hormone receptor TRβ, increased towards term.  Upregulation of DIO1 and DIO2 enzyme activities 462 
have been demonstrated previously in ovine fetal PAT over the same period of gestation, in part 463 
due to the prepartum rise in plasma cortisol (53, 54).  Increased DIO1 enzyme activity in the PAT, 464 
and liver and kidney, of the sheep fetus near term are likely to be responsible for the increase in 465 
plasma T3 seen close to term (54).  Hypothyroidism in utero had contrasting effects on the 466 
expression of DIO1 and DIO2 mRNA in ovine fetal PAT: DIO1 was reduced to negligible levels and 467 
DIO2 was increased in TX fetuses, in line with previous findings on deiodinase enzyme activity in 468 
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adipose and other tissues of hypothyroid sheep and rat fetuses (47, 53, 55).  Indeed, bioinformatic 469 
analysis identified DIO1 as the top-ranked gene affected by fetal TX in the current study with a 7.4-470 
fold decrease in expression levels.  Although DIO2 enzyme activity is much lower than DIO1 in 471 
ovine fetal PAT (54), the increase in DIO2 mRNA abundance may be an adaptive response to 472 
maintain local T3 production in hypothyroid conditions.  The molecular mechanisms responsible 473 
for the tissue-specific control of deiodinase expression by thyroid hormone deficiency before birth 474 
remain to be established, although a TRE has been identified in the human Dio1 gene (56).  Within 475 
the PAT of TX sheep fetuses, the mRNA abundances of both thyroid hormone receptors, TRα and 476 
β, were increased in an apparent attempt to maintain local sensitivity to thyroid hormones in the 477 
face of systemic hypothyroidism.  Fetal thyroid hormone deficiency appeared to upregulate TRα 478 
gene expression without affecting the relative proportions of the splice variants α1 and α2. 479 
 During hypothyroidism in utero, activation of adipogenesis, suppression of thermogenic 480 
capacity, and exposure of the fetus to high circulating levels of insulin and adipocytokines may 481 
have consequences for adipose function and insulin sensitivity in the longer term (8).  Human 482 
infants exposed to hyperinsulinemia before birth, such as those born to obese mothers, have 483 
greater percentage body fat, higher umbilical cord leptin concentration and raised indicators of 484 
insulin resistance compared to those born to lean mothers (57).  In the present study, genomic 485 
pathways associated with insulin resistance were identified as enriched in PAT from TX fetuses.  486 
Furthermore, since there is a link between adiposity in the neonate and child (58), these findings 487 
suggest that the development of fetal adipose tissue and enhancement of insulin resistance 488 
pathways may predispose offspring hypothyroid in utero to obesity and metabolic disease in later 489 
life.  Several studies worldwide have shown that children born with CH have a greater body mass 490 
index and are more at risk of obesity, insulin resistance and NAFL in early and young adult life 491 
compared with the general population, even when diagnosed and treated with T4 soon after birth 492 
(2-6).  Moreover, infants with more moderate reductions in thyroid hormones associated with 493 
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prematurity or intrauterine growth retardation are also at greater risk of obesity and 494 
cardiometabolic dysfunction in later life (7, 8).  Collectively, these findings suggest that exposure 495 
to hypothyroidism in utero permanently alters adipose tissue development with consequences for 496 
adult health.  Further investigations are required, however, to determine whether these 497 
programming effects arise directly from the altered adipose phenotype and/or indirectly from 498 
other changes in endocrine activity, metabolism or appetite regulation that affect adult adiposity.  499 
For example, antithyroid drug treatment in pregnant rats leads to hyperleptinaemia in the adult 500 
offspring and alterations in hypothalamic leptin signalling molecules indicative of leptin resistance 501 
(59).  Hyperinsulinaemia and overgrowth of UL adipose tissue in sheep fetuses infused with 502 
glucose were also associated with changes to the expression of neuropeptides in the appetite-503 
regulatory regions of the hypothalamus (37).  Elucidation of the molecular pathways influenced by 504 
thyroid deficiency in utero, and the long-term consequences for physiological function in a range 505 
of tissues, will enable greater understanding of the health outcomes in offspring exposed to 506 
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Figure Legends 678 
1.  Mean (± SEM) measurements of (A) perirenal adipose tissue (PAT) composition, (B) relative PAT 679 
mass and (C) unilocular (UL) adipocyte perimeter in sham and thyroidectomised (TX) fetuses at 680 
129 and 143 days of gestation (dGA).  * Significantly different from sham fetuses at same 681 
gestational age; + significantly different from fetuses at 129 dGA in the same treatment group, 682 
P<0.05.  Representative histological images of perirenal adipose tissue taken from (D) sham and 683 
(E) TX sheep fetuses at 143 dGA.  Haematoxylin and eosin stain. 684 
 685 
2.  KEGG pathway and biological process (BP) bar plots using RNA-sequencing data from perirenal 686 
adipose tissue taken from sham and thyroidectomised (TX) fetuses at 129 and 143 days of 687 
gestation (dGA).  Selected relevant KEGG (A) and BP ontology (B) pathway bar plots indicating the 688 
number of up and down-regulated genes when the data were compared by treatment (TX and 689 
sham); the red and blue bars represent up and down-regulated genes, respectively.  690 
 691 
3.  Mean (± SEM) abundance of (A) uncoupling protein-1 (UCP1) mRNA, (B) UCP1 mRNA relative to 692 
the percentage volume of multilocular (ML) adipose tissue, and (C) UCP1 protein relative to the 693 
percentage volume of ML adipose tissue and (D) citrate synthase (CS) activity, in perirenal adipose 694 
tissue taken from sham and thyroidectomised (TX) fetuses at 129 and 143 days of gestation (dGA).  695 
* Significantly different from sham fetuses at same gestational age; + significantly different from 696 
fetuses at 129 dGA in the same treatment group, P<0.05.  AU, arbitrary units.  697 
 698 
4.  Mean (± SEM) mRNA abundance of (A) iodothyronine deiodinase-1 (DIO1), (B) DIO2, (C) thyroid 699 
hormone receptor α1 (TRα1), (D) TRα2 and (E) TRβ in perirenal adipose tissue taken from sham 700 
and thyroidectomised (TX) fetuses at 129 and 143 days of gestation (dGA).  * Significantly different 701 
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from sham fetuses at same gestational age; + significantly different from fetuses at 129 dGA in the 702 
same treatment group, P<0.05.  AU, arbitrary units. 703 
 704 
Supplementary Figure Legends  705 
S1.  Principal component analysis (PCA)-based clustering, PC1 and PC2, and heatmap plots using 706 
RNA-sequencing data from perirenal adipose tissue taken from sham and thyroidectomised (TX) 707 
fetuses at 129 and 143 days of gestation (dGA).  (A) Unbiased PCA-based clustering of treatment 708 
(TX and sham) with gestational age (129 and 143 dGA).  The 500 most variable genes and the two 709 
principal components were used for clustering and to describe the variance between the subsets.  710 
(B) Top 25 genes that explained the variance by treatment (TX and sham) within PC1.  (C) Top 25 711 
genes that explained the variance by gestational age (129 and 143 dGA) within PC2.  (D) Clustering 712 
heatmap analysis for the top 272 genes under the DESeq2 comparison by treatment (TX and sham) 713 
with Padj < 0.05 and absolute log2 fold change ≥ 2.  714 
 715 
S2.  Volcano plots using RNA-sequencing data from perirenal adipose tissue taken from sham and 716 
thyroidectomised (TX) fetuses at 129 and 143 days of gestation (dGA).  Volcano plots comparing 717 
data by treatment (A: TX and sham) and gestational age (B: 129 and 143 dGA), and between and 718 
within treatment and gestational age groups (C-F).  Red and blue dots represent up and down-719 
regulated differentially expressed genes, respectively (absolute log2 fold change ≥ 1, Padj < 0.05).   720 
 721 
S3.  Differentially expressed gene (DEG) intersection plot using RNA-sequencing data from 722 
perirenal adipose tissue taken from sham and thyroidectomised (TX) fetuses at 129 and 143 days 723 
of gestation (dGA).  (A) Number of significant DEGs, with an absolute log2 fold change ≥ 1, Padj < 724 
0.05, identified from comparisons between and within treatment and gestational age groups.  (B) 725 
Number of unique significant DEGs for each comparison. 726 
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 727 
S4.  KEGG pathway heatmap and bar plot using RNA-sequencing data from perirenal adipose tissue 728 
taken from sham and thyroidectomised (TX) fetuses at 129 and 143 days of gestation (dGA).  (A) 729 
KEGG pathway heatmap for data stratified by treatment and gestational age, and between and 730 
within treatment and gestational age groups.  (B) KEGG pathway bar plot indicating the number of 731 
up and down-regulated genes when the data were compared by treatment (TX and sham); the red 732 
and blue bars represent up and down-regulated genes, respectively.  733 
 734 
S5.  Biological process (BP) ontology pathway bar plot using RNA-sequencing data from perirenal 735 
adipose tissue taken from sham and thyroidectomised (TX) fetuses at 129 and 143 days of 736 
gestation (dGA).  (A) BP ontology pathway heatmap for data stratified by treatment and 737 
gestational age, and between and within treatment and gestational age groups.  (B) BP ontology 738 
pathway bar plot indicating the number of up and down-regulated genes when the data were 739 
compared by treatment (TX and sham); the red and blue bars represent up and down-regulated 740 
genes, respectively. 741 
 742 
S6.  Mean (± SEM) mRNA and protein abundance of (Ai, ii) proliferating cell nuclear antigen 743 
(PCNA), (Bi, ii) peroxisome proliferator-activated receptor γ (PPARγ), (Ci, ii) insulin receptor (InsR), 744 
(Di, ii) protein kinase β 1 (Akt1), (Ei, ii) Akt2, (Fi, ii) mammalian target of rapamycin (mTOR, 745 
phosphorylated protein), (Gi, ii) S6 kinase (S6K, phosphorylated protein) and (Hi, ii) glucose 746 
transporter-4 (GLUT4), in perirenal adipose tissue taken from sham and thyroidectomised (TX) 747 
fetuses at 129 and 143 days of gestation (dGA).  * Significantly different from sham fetuses at 748 
same gestational age; + significantly different from fetuses at 129 dGA in the same treatment 749 
group, P<0.05.  AU, arbitrary units.  750 
 751 
 34 
S7.  Mean (± SEM) mRNA abundance of (A) insulin-like growth factor-I (IGFI), (B) IGFII, (C) leptin 752 
and the adrenergic receptors (D) α1A, (E) α1D, (F) α2A, (G) β1, (H) β2 and (I) β3 in perirenal 753 
adipose tissue taken from sham and thyroidectomised (TX) fetuses at 129 and 143 days of 754 
gestation (dGA).  * Significantly different from sham fetuses at same gestational age; + significantly 755 
different from fetuses at 129 dGA in the same treatment group, P<0.05.  AU, arbitrary units. 756 
 757 
S8. A Sashimi plot to show the expression of differentially spliced transcripts of the thyroid 758 
hormone receptor (TR), TRα1 and TRα2, in perirenal adipose tissue taken from sham and 759 
thyroidectomised (TX) fetuses at 129 and 143 days of gestation (dGA).  The annotation bars 760 
represent TRα1 in red and TRα2 in green. 761 
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